Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 801 results for "quest diagnostics"

Quest Diagnostics Inc (DGX) SVP Catherine T. Doherty Sells 29,550 Shares
American Banking News

Insider Selling: Quest Diagnostics Inc (DGX) SVP Sells $2,199,...

Quest Diagnostics Inc (NYSE:DGX) SVP Catherine T. Doherty sold 29,550 shares of the company's stock in a transaction that occurred on Monday, April 25th. The stock was sold at an average price of $74.45, for a total transaction of $2,199,997.50. WKRB News, 38 minutes ago
Weekly Investment Analysts Ratings Updates for Quest Diagnostics (DGX) American Banking News - Earnings, 3 hours ago
Caribbean Business Online

Quest Diagnostics' Zika RT-PCR test receives US FDA emergency use authorization

Quest Diagnostics, the world's leading provider of diagnostic information services, has received a US Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the Zika Virus RNA Qualitative Real-Time RT-PCR test (Zika RT-PCR test).
 PharmaBiz1 day ago FDA grants Quest Diagnostics lab emergency use of Zika virus diagnostic  Medical Device Daily1 day ago First widely available Zika test OK'd for emergency use  Yahoo! Finance2 days ago FDA Authorizes New Zika Test for Emergency Use  Caribbean Business Online2 days ago

Understanding Quest Diagnostics Valuation Multiple Compared to Those of Peers

The Story Behind Quest Diagnostics' Valuation-Driving Strategies Valuation multiples On April 26, 2016, Quest Diagnostics (DGX) was trading at a forward PE (price-to-earnings) multiple of about 13.7x. Since January 1, 2016, the company has traded ...
 Yahoo! Finance UK and Ireland3 days ago

Analysts: Quest Likely to Do Deals First, Stock Buybacks Second, with Focus Sale Proceeds

Quest Diagnostics ( (DGX - Get Report) ) is likely to use proceeds from the sale of Focus Diagnostics Inc. to "do more hospital outreach deals first, and buy back stock second," according to a Thursday note by Canaccord Genuity analysts Mark Massaro ...
 TheStreet.com1 week ago

Quest Diagnostics Incorporated (DGX) - Product Pipeline Analysis, 2016 Update

GlobalData Summary Quest Diagnostics Incorporated (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive ...
 MarketResearch.com4 days ago Quest Diagnostics' (DGX) CEO Steve Rusckowski on Q1 2016 Results - Earnings Call Transcript  Seeking Alpha1 week ago Quest Diagnostics Q1 16 Earnings Conference Call At 8:30 AM ET  Nasdaq1 week ago Tata Consultancy Services' (TCS.BO) CEO N. Chandrasekaran on Q4 2016 Results - Earnings Call Transcript  Seeking Alpha1 week ago

Quest Diagnostics Inc reaffirms FY 2016 guidance

Quest Diagnostics Inc:Says its FY 2016 outlook, before special items, remains unchanged.Sees FY 2016 revenues to be between $7.52 billion and $7.59 billion, an increase of 1.5% to 2.5% over 2015 revenues on an equivalent basis.Sees FY 2016 adjusted ...
 Reuters UK1 week ago Quest 2016 Outlook, Before Special Items, Remains Unchanged - Quick Facts  RTTNews.com1 week ago

BRIEF-Biocept says Selecto blood-based test will now be accessible to patients in Mexico through agreement with Quest Diagnostics

News and Media Division of Thomson Reuters Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, ...
 Reuters UK1 week ago Biocept Continues International Expansion through Agreement with Quest Diagnostics Mexico  Benzinga.com1 week ago Biocept ties up deal in Mexico for lung cancer diagnostic  Proactive week ago Biocept, Inc. Continues International Expansion Through Agreement With Quest Diagnostics Mexico  BioSpace1 week ago

Quest Diagnostics (DGX) Marked As A Barbarian At The Gate

Trade-Ideas LLC identified Quest Diagnostics ( DGX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate. In addition to specific proprietary factors, Trade-Ideas identified Quest ...
 TheStreet.com1 week ago

Quest Diagnostics meets 1Q profit forecasts

Quest Diagnostics matches 1Q earnings expectations, tops revenue forecasts 14
 Yahoo! Finance1 week ago

DEFA14A - QUEST DIAGNOSTICS INC (0001022079) (Filer)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material SEC Accession No. 0001022079-16-000251 Filing Date 2016-04-27 2016-04-27 08:58:24 Filing Date Changed 2016-04-27 Effectiveness Date 2016-04-27 ...
 SEC Filings4 days ago NO ACT - QUEST DIAGNOSTICS INC (0001022079) (Filer)  SEC Filings2 weeks ago DEF 14A - QUEST DIAGNOSTICS INC (0001022079) (Filer)  SEC3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - quest diagnostics
Get updated on latest news & your favorite topics right in your inbox!
More     Less